Pulmonary interstitial fibrosis and haemosiderin-laden macrophages: Late following heart transplantation

Respiratory Medicine

Volumn 90, Issue 9, 1996, Pages 547-551

  Egan, J J ^a   Martin, N ^a   Hasleton, P S ^a   Yonan, N ^a   Rahman, A N ^a   Campbell, C A ^a   Deiraniya, A K ^a   Carroll, K B ^a   Woodcock, A A ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSIDERIN;

ADULT; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; FIBROSING ALVEOLITIS; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG DIFFUSION; LUNG LAVAGE; MALE; MICROSCOPY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

EID: 0029805164     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90147-X     Document Type: Article

References (17)

1. Ohar J, Osterloh J, Ahmed N, Miller L. Diffusing capacity decreases after heart transplantation. Chest 1993; 103: 857-861.
2. Ravenscraft SA, Gross CR, Kubo SH et al. Pulmonary function after successful heart transplantation: One year follow up. Chest 1993; 103: 54-58.
3. Bush A, Gabriel R. Pulmonary function in chronic renal failure: effects of dialysis and transplantation. Thorax 1991; 46: 424-428.
4. Egan JJ, Kalra S, Yonan N, Hasleton PS, Brooks N, Woodcock AA. Pulmonary diffusion abnormalities in heart transplant recipients: relationship to cytomegalovirus. Chest 1993; 104: 1085-1089.
5. Groen HJ, Bogaard JM, Balk AH, Kho SG, Hop WC, Hilvering C. Diffusion capacity in heart transplant recipients. Chest 1992; 102: 456-460.
6. Grebski E, Hess T, Hold G, Speich R, Russi E. Diagnostic value of hemosiderin laden macrophages in bronchalveolar lavage. Chest 1992; 102: 1794-1799.
7. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 (Suppl. 16): 5-40.
8. Coates JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardisation of the measurement of transfer factor(diffusing capacity). Eur Respir J 1993; 6 (Suppl. 16): 41-52.
9. Morris DJ, Lomax J, Craske J, Longson M, Fox AJ. Effects of centrifugal enhancement of infectivity on the rapid detection of human cytomegalovirus in cell culture by immunofluorescence using a monoclonal antibody to immediate early nuclear antigen. Serodiagn Immunother Infect Dis 1987; 1: 141-152.
10. Kahn FW, Jones JM, England DM. Diagnosis of pulmonary haemorrhage in the immunocompromised host. Am Rev Respir Dis 1987; 136: 155-160.
11. Harris P, Heath D. Structural changes in the lung associated with pulmonary venous hypertension. In The Human Pulmonary Circulation 3rd Edition. Edinburgh: Churchill-Livingstone, 1986, pp. 329-344.
12. Ramirez A, Grimes ET, Ablemann WH. Regression of pulmonary vascular changes following mitral valvuloplasty. An anatomic and physiologic case study. Am J Med 1986; 45: 975-982.
13. Ohno K, Nakahara K, Hirose H, Nahono S, Kawashima Y. Effects of valvular surgery on overall and regional lung function in patients with mitral stenosis. Chest 1987; 92: 224-228.
14. Rhodes KM, Evemy K, Nairman S, Gibson GJ. Effects of mitral valve surgery on static lung function and exercise performance. Thorax 1985; 40: 107-112.
15. Davies SW, Bailey J, Keegan J, Balcolme R, Rod RM, Lipkin DP. Reduced pulmonary microvascular permeability in severe chronic left heart failure. Am Heart J 1992; 124: 137-142.
16. Kahan BD. Cyclosporine. N Engl Med J 1989; 321: 1725-1738.
17. Mihatsch MJ, Antonovych T, Bohman O et al. Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 1994; 4: 23-32.